Combination of quercetin and hyperoside has anticancer effects on renal cancer cells through inhibition of oncogenic microRNA-27a

Oncology Reports

Volumn 31, Issue 1, 2014, Pages 117-124

  Li, Wei ^a   Liu, Min ^a   Xu, Yun Fei ^a   Feng, Yuan ^b   Che, Jian Ping ^a   Wang, Guang Chun ^a   Zheng, Jun Hua ^a  

^a TONGJI UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Hyperoside; MicroRNA 27a; Quercetin; Renal cancer

Indexed keywords

CASPASE 3; HYPERIN; MESSENGER RNA; MICRORNA; MICRORNA 27A; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN ZBTB10; QUERCETIN; REACTIVE OXYGEN METABOLITE; REPRESSOR PROTEIN; SURVIVIN; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; TRANSCRIPTION FACTOR SP4; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CARCINOMA CELL; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME INDUCTION; GENE CONTROL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IC 50; KIDNEY CARCINOMA; PHARMACOGENETICS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FOLDING; SURVIVIN GENE; TRANSCRIPTION REGULATION; TUMOR VASCULARIZATION;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIOXIDANTS; APOPTOSIS; CARCINOMA, RENAL CELL; CASPASE 3; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; QUERCETIN; REACTIVE OXYGEN SPECIES; REPRESSOR PROTEINS; SP1 TRANSCRIPTION FACTOR; SP3 TRANSCRIPTION FACTOR; SP4 TRANSCRIPTION FACTOR;

EID: 84891935266     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2811     Document Type: Article

References (36)

1. Miyamoto H, Miller JS, Fajardo DA, et al: Non-invasive papillary urothelial neoplasms: the 2004 WHO/ISUP classification system. Pathol Int 60: 1-8, 2010.
2. Zisman A, Pantuck AJ, Wieder J, et al: Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol 20: 4559-4566, 2002.
3. Eble JN, Sauter G, Epstein JI and Sesterhenn I (eds): World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs. IARC Press, Lyon, 2005.
4. Theodoratou E, Kyle J, Cetnarskyj R, et al: Dietary flavonoids and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 16: 684-693, 2007.
5. Kim MJ, Kim YJ, Park HJ, et al: Apoptotic effect of red wine polyphenols on human colon cancer SNU-C4 cells. Food Chem Toxicol 44: 898-902, 2006.
6. Mertens-Talcott SU and Percival SS: Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells. Cancer Lett 218: 141-151, 2005.
7. Chu CY, Lee HJ, Chu CY, et al: Protective effects of leaf extract of Zanthoxylum ailanthoides on oxidation of low-density lipoprotein and accumulation of lipid in differentiated THP-1 cells. Food Chem Toxicol 47: 1265-1271, 2009.
8. Gao LL, Feng L, Yao ST, et al: Molecular mechanisms of celery seed extract induced apoptosis via S phase cell cycle arrest in the BGC-823 human stomach cancer cell line. Asian Pac J Cancer Prev 12: 2601-2606, 2011.
9. Mertens-Talcott SU, Talcott ST and Percival SS: Low concentrations of quercetin and ellagic acid synergistically influence proliferation, cytotoxicity and apoptosis in MOLT-4 human leukemia cells. J Nutr 133: 2669-2674, 2003.
10. George J, Singh M, Srivastava AK, et al: Resveratrol and black tea polyphenol combination synergistically suppress mouse skin tumors growth by inhibition of activated MAPKs and p53. PLoS One 6: e23395, 2011.
11. Srivastava RK, Tang SN, Zhu W, et al: Sulforaphane synergizes with quercetin to inhibit self-renewal capacity of pancreatic cancer stem cells. Front Biosci (Elite Ed) 3: 515-528, 2011.
12. Tang SN, Singh C, Nall D, et al: The dietary bioflavonoid quercetin synergizes with epigallocatechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition. J Mol Signal 5: 14, 2010.
13. Chadalapaka G, Jutooru I, Burghardt R and Safe S: Drugs that target specificity proteins downregulate epidermal growth factor receptor in bladder cancer cells. Mol Cancer Res 8: 739-750, 2010.
14. Chadalapaka G, Jutooru I, Chintharlapalli S, et al: Curcumin decreases specificity protein expression in bladder cancer cells. Cancer Res 68: 5345-5354, 2008.
15. Chintharlapalli S, Papineni S, Abdelrahim M, et al: Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo- 18β-olean-1,12-dien-30-oate in colon cancer cells. Int J Cancer 125: 1965-1974, 2009.
16. Jutooru I, Chadalapaka G, Abdelrahim M, et al: Methyl 2-cyano-3,12-dioxooleana-1,9-dien-28-oate decreases specificity protein transcription factors and inhibits pancreatic tumor growth: role of microRNA-27a. Mol Pharmacol 78: 226-236, 2010.
17. Jutooru I, Chadalapaka G, Lei P and Safe S: Inhibition of NF-κB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation. J Biol Chem 285: 25332-25344, 2011.
18. Frémont L: Biological effects of resveratrol (Review). Life Sci 66: 663-673, 2000.
19. Brauns SC, Dealtry G, Milne P, et al: Caspase-3 activation and induction of PARP cleavage by cyclic dipeptide Cyclo(Phe-Pro) in HT-29 cells. Anticancer Res 25: 4197-4202, 2005.
20. Meng Q, Velalar CN and Ruan R: Effects of epigallocatechin-3-gallate on mitochondrial integrity and antioxidative enzyme activity in the aging process of human fibroblast. Free Rad Biol Med 44: 1032-1041, 2008.
21. 2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res 67: 11001-11011, 2007.
22. Fresco P, Borges F, Diniz C and Marques MP: New insights on the anticancer properties of dietary polyphenols. Med Res Rev 26: 747-766, 2006.
23. Schumacker PT: Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell 10: 175-176, 2006.
24. Fiander H and Schneider H: Dietary ortho phenols that induce glutathione S-transferase and increase the resistance of cells to hydrogen peroxide are potential cancer chemopreventives that act by two mechanisms: the alleviation of oxidative stress and the detoxification of mutagenic xenobiotics. Cancer Lett 156: 117-124, 2000.
25. Hsu SC, Lu JH, Kuo CL, et al: Crude extracts of Solanum lyratum induced cytotoxicity and apoptosis in a human colon adenocarcinoma cell line (colo 205). Anticancer Res 28: 1045-1054, 2008.
26. SchlachtermanA, Valle F, Wall KM, et al: Combined resveratrol, quercetin, and catechin treatment reduces breast tumor growth in a nude mouse model. Transl Oncol 1: 19-27, 2008.
27. Tan J, Wang B and Zhu L: Regulation of survivin and Bcl-2 in HepG2 cell apoptosis induced by quercetin. Chem Biodivers 6: 1101-1110, 2009.
28. Shakibaei M, John T, Seifarth C and Mobasheri A: Resveratrol inhibits IL-1β-induced stimulation of caspase-3 and cleavage of PARP in human articular chondrocytes in vitro. Ann NY Acad Sci 1095: 554-563, 2007.
29. Wang ZQ, Stingl L, Morrison C, et al: PARP is important for genomic stability but dispensable in apoptosis. Genes Dev 11: 2347-2358, 1997.
30. Hsu CP, Lin YH, Chou CC, et al: Mechanisms of grape seed procyanidin-induced apoptosis in colorectal carcinoma cells. Anticancer Res 29: 283-289, 2009.
31. Lee HS, Park CK, Oh E, et al: Low SP1 expression differentially affects intestinal-type compared with diffuse-type gastric adenocarcinoma. PLoS One 8: e55522, 2013.
32. Deacon K, Onion D, Kumari R, et al: Elevated SP-1 transcription factor expression and activity drives basal and hypoxia-induced vascular endothelial growth factor (VEGF) expression in non-small cell lung cancer. J Biol Chem 287: 39967-39981, 2012.
33. Kim K, Chadalapaka G, Lee SO, et al: Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer. Oncogene 31: 1034-1044, 2012.
34. Lynam-Lennon N, Maher SG and Reynolds JV: The roles of microRNA in cancer and apoptosis (Review). Biol Rev Camb Philos Soc 84: 55-71, 2009.
35. Tang W, Zhu J, Su S, et al: MiR-27 as a prognostic marker for breast cancer progression and patient survival. PLoS One 7: e51702, 2012.
36. Noratto GD, Jutooru I, Safe S, et al: The drug resistance suppression induced by curcuminoids in colon cancer SW?480 cells is mediated by reactive oxygen species-induced disruption of the microRNA-27a-ZBTB10-Sp axis. Mol Nutr Food Res 57: 1638-1648, 2013.